Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-10T09:01:53.071Z Has data issue: false hasContentIssue false

Clinician and caregiver agreement on neuropsychiatric symptom severity: a study using the Neuropsychiatric Inventory – Clinician rating scale (NPI-C)

Published online by Cambridge University Press:  13 March 2014

Shirin Zaidi*
Affiliation:
Department of Psychology, Stichting Topaz, Leiden, the Netherlands
Martin G. Kat
Affiliation:
Department of Geriatric Medicine, Medical Centre Alkmaar, Alkmaar, the Netherlands
Jos F.M. de Jonghe
Affiliation:
Department of Geriatric Medicine, Medical Centre Alkmaar, Alkmaar, the Netherlands
*
Correspondence should be addressed to: Shirin Zaidi, MSc, Department of Psychology, Stichting Topaz, Willem de Zwijgerlaan 44, 2316 GJ Leiden, the Netherlands. Phone: +31-71-4057900; Fax: +31-71-4057999. Email: s.zaidi@topaz.nl.

Abstract

Background:

Neuropsychiatric symptoms (NPS) are highly prevalent in dementia. The recently developed Neuropsychiatric Inventory – Clinician rating scale (NPI-C) includes clinical judgment and new symptom domains. Our objective was to evaluate NPI-C reliability and to compare caregiver and clinician ratings across the range of mild to severe cognitive impairment.

Methods:

This is a cross-sectional observational study. Participants were geriatric memory clinic patients and nursing-home residents (n = 30) with an established diagnosis of dementia or Mild Cognitive Impairment (MCI). A psychiatrist (MK) interviewed caregiver–patient dyads using the NPI-C. Neuropsychological tests and Mini-Mental State Examination (MMSE) were used to assess cognitive impairment. Two NPI-C caregiver interviews were videotaped and rated by psychologists and geriatricians. Intra-class correlations (ICCs) were used to examine inter-rater agreement. Correlation coefficients were calculated to evaluate caregiver and psychiatrist NPI-C ratings. Disagreement between caregiver and clinician was expressed in delta scores and examined across the range of mild to severe cognitive impairment, using Levene's homogeneity of variances tests.

Results:

Inter-rater agreement on ratings of two caregiver videos was high (ICC = 0.99–1.0). Clinician–caregiver concordance on NPI-C total severity ratings was high (r = 0.77). Variability in clinician–caregiver concordance was associated with cognitive impairment: MMSE (P = 0.02), CAMCOG-R (Cambridge Cognitive Examination-revised) total scores (P = 0.02), CAMCOG-R Memory scores (P = 0.04) and Language scores (P = 0.01).

Conclusions:

The NPI-C is a reliable measure of NPS in patients with MCI or dementia. Clinician–caregiver agreement on NPS severity may vary with cognitive impairment, underlining the importance of clinician-based measures of NPS.

Type
Research Article
Copyright
Copyright © International Psychogeriatric Association 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aalten, P. et al. (2007). Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: part I. Dementia and Geriatric Cognitive Disorders, 24, 457463. doi: 10.1159/000110738.Google Scholar
Cohen-Mansfield, J. and Wirtz, P. W. (2011). Predictors of entry to the nursing home: does length of follow-up matter? Archives of Gerontology and Geriatrics, 53, 309315. doi: 10.1016/j.archger.2010.12.009.Google Scholar
Craig, D., Mirakhur, A., Hart, D. J., McIlroy, S. P. and Passmore, A. P. (2005). A cross-sectional study of neuropsychiatric symptoms in 435 patients with Alzheimer's disease. American Journal of Geriatric Psychiatry, 13, 460468. doi: 10.1176/app1.ajgp.13.6.460.CrossRefGoogle ScholarPubMed
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A. and Gornbein, J. (1994). The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology, 44, 23082314. doi: 10.1212/WNL.44.12.2308.CrossRefGoogle ScholarPubMed
Cummings, J. L., Nadel, A., Masterman, D. and Cyrus, P. A. (2001). Efficacy of metrifonate in improving the psychiatric and behavioral disturbances of patients with Alzheimer's disease. Journal of Geriatric Psychiatry and Neurology, 14, 101108. doi: 10.1177/089198870101400211.Google Scholar
de Jonghe, J. F., Kat, M. G., Kalisvaart, C. J. and Boelaarts, L. (2003). Neuropsychiatric inventory questionnaire (NPI-Q): a validity study of the Dutch form. Tijdschrift voor Gerontologie en Geriatrie, 34, 7477.Google Scholar
de Medeiros, K. et al. (2010). The Neuropsychiatric Inventory – Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia. International Psychogeriatric Association, 22, 984994. doi: 10.1017/S1041610210000876.CrossRefGoogle ScholarPubMed
Derix, M. M. et al. (2002). Cambridge Examination for Mental Disorders – revised (CAMDEX-R/N). Amsterdam, the Netherlands: Pearson Assessment and Information B.V. Google Scholar
Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189198.Google Scholar
Huang, S. S., Lee, M. C., Liao, Y. C., Wang, W. F. and Lai, T. J. (2012). Caregiver burden associated with behavioral and psychological symptoms of dementia (BPSD) in Taiwanese elderly. Archives of Gerontology and Geriatrics, 55, 5559. doi: 10.1016/j.archger.2011.04.009.Google Scholar
Iverson, G. L., Hopp, G. A., DeWolfe, K. and Solomons, K. (2002). Measuring change in psychiatric symptoms using the Neuropsychiatric Inventory: Nursing Home version. International Journal of Geriatric Psychiatry, 17, 438443. doi: 10.1002/gps.617.Google Scholar
Kat, M. G., de Jonghe, J. F., Aalten, P., Kalisvaart, C. J., Droes, R. M. and Verhey, F. R. (2002). Neuropsychiatric symptoms of dementia: psychometric aspects of the Dutch Neuropsychiatric Inventory (NPI). Tijdschrift voor Gerontologie en Geriatrie, 33, 150155.Google ScholarPubMed
Kaufer, D. I. et al. (1998). Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the Neuropsychiatric Inventory Caregiver Distress Scale. Journal of the American Geriatric Society, 46, 210215.Google Scholar
Lyketsos, C. G., Lopez, O., Jones, B., Fitzpatrick, A. L., Breitner, J. and DeKosky, S. (2002). Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. Journal of the American Medical Association, 288, 14751483. doi: 10.1001/jama.288.12.1475.CrossRefGoogle ScholarPubMed
Lyketsos, C. G. et al. (2001). Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups: the Cache County study. International Journal of Geriatric Psychiatry, 16, 10431053. doi: 10.1002/gps:448. doi:10.1002/gps.448.Google Scholar
Maidment, I. D., Fox, C. G., Boustani, M., Rodriguez, J., Brown, R. C. and Katona, C. L. (2008). Efficacy of memantine on behavioral and psychological symptoms related to dementia: a systematic meta-analysis. The Annals of Pharmacotherapy, 42, 3238. doi:101345/aph.1k372.CrossRefGoogle ScholarPubMed
Onder, G., Liperoti, R., Soldato, M., Cipriani, M. C., Bernabei, R. and Landi, F. (2007). Depression and risk of nursing home admission among older adults in home care in Europe: results from the Aged in Home Care (AdHOC) study. Journal of Clinical Psychiatry, 68, 13921398.Google Scholar
Perneczky, R., Wagenpfeil, S., Komossa, K., Grimmer, T., Diehl, J. and Kurz, A. (2006). Mapping scores onto stages: mini-mental state examination and clinical dementia rating. The American Journal of Geriatric Psychiatry, 14, 139144. doi: 10.1097/01.jpg0000192478.82189.a8.CrossRefGoogle ScholarPubMed
Rodda, J., Morgan, S. and Walker, Z. (2009). Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine. International Psychogeriatrics, 21, 813824. doi: 10.1017s1041610209990354.Google Scholar
Verhey, F. R. et al. (2003). Cross-national comparisons of the Cambridge Cognitive Examination-revised: the CAMCOG-R: results from the European Harmonization Project for Instruments in Dementia. Age Ageing, 32, 534540.CrossRefGoogle ScholarPubMed
Zuidema, S. U., Derksen, E., Verhey, F. R. and Koopmans, R. T. (2007). Prevalence of neuropsychiatric symptoms in a large sample of Dutch nursing home patients with dementia. International Journal of Geriatric Psychiatry, 22, 632638. doi:10.1002/gps.1722.CrossRefGoogle Scholar
Zuidema, S. U. et al. (2011). Assessing neuropsychiatric symptoms in nursing home patients with dementia: reliability and Reliable Change Index of the Neuropsychiatric Inventory and the Cohen-Mansfield Agitation Inventory. International Journal of Geriatric Psychiatry, 26, 127134. doi: 10.1002/gps.2499.CrossRefGoogle ScholarPubMed